VivoSeq
Other

Chronic Pelvic Pain Syndrome

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Chronic Pelvic Pain Syndrome is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

0/100

Attrition Rate

75/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Terminated3 · 75%
Recruiting1 · 25%

Clinical Trials

Trial Activity

Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
Terminated·NNorthwestern University·Phase 4·NCT02385266·24 enrolled
Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III
Terminated·UUniversity of Washington·Phase 4·NCT00194597·30 enrolled
Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome
Terminated·—·Phase 3·NCT00464373·11 enrolled
Sacral Neuromodulation for the Treatment of Chronic Pelvic Pain
Recruiting·CCorewell Health East·Preclinical·NCT06150599·25 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)